Why the Appen share price could come under pressure today

The Appen Ltd (ASX:APX) share price could come under pressure today after insiders sold almost $70 million worth of the company's shares…

The Appen Ltd (ASX: APX) share price will be one to watch this morning after an announcement by the global leader in the development of high-quality, human-annotated training data for machine learning and artificial intelligence.

What did Appen announce?

Appen's announcement after the market close on Thursday revealed that a number of executives have been selling shares this week.

The biggest seller was Non-Executive Chairman, Chris Vonwiller. He offloaded 2 million Appen shares on-market for an average of $29.00 per share. This represents a total consideration of $58 million.

Also selling shares was the company's CEO and Managing Director, Mark Brayan. He sold 95,535 shares for an average of $30.60 per share. This equates to a total consideration of approximately $2.9 million.

And finally, another insider that was selling shares was Non-Executive Director, Bill Pulver. Mr Pulver sold 275,000 shares on-market for an average of $30.6865 per share. This represents a total consideration of $8.4 million.

Why were they selling shares?

Appen helpfully provided explanations for each of the sales.

Mr Vonwiller sold his shares for a number of personal reasons, including philanthropic endeavours.

Whereas the company's CEO was selling shares to satisfy tax obligations and diversify personal investments. The latter was the reason Mr Pulver gave for selling his shares.

It is worth noting that all three directors still have sizeable shareholdings, even after these sales.

Should you be concerned?

Insider selling rarely goes down well with investors. The theory is that if a director was confident its shares would go a lot higher from here, they wouldn't sell them today. So, the decision to sell is often interpreted to be a bearish indicator.

However, I think the explanations they have given is reasonable. And as I mentioned above, they still have plenty of their wealth tied up in the company.

In light of this, if the Appen share price were to pullback meaningfully on the news, I would consider picking up shares.

After all, given the strong growth potential the company has over the next decade, I believe its shares could be a lot higher than this level in 2030.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Opinions

These are the best 3 ASX growth shares I own and I'd buy more of today

I’m bullish about the earnings potential of these three ASX growth shares.

Read more »

Man using his device in an airport.
Broker Notes

This high-quality ASX 200 share could rise 60%

A leading broker expects a good yield and major upside from this stock.

Read more »